Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,684,345
-$293,016 QoQ
Shares Held
21,247
-0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.15%
of 13F equity value
Holder Rank
#748
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cairn Investment Group, Inc. holds $15,565,541 across 7 Drug Manufacturers - General names. GILD ranks #3 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
54,875 | $7,051,437 | |
| 2 | LLY |
ELI LILLY & Co
|
2,610 | $3,130,512 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
21,247 | $2,684,345 | |
| 4 | BIIB |
Biogen Inc.
|
8,043 | $1,737,770 | |
| 5 | NVO |
Novo Nordisk A S
|
9,333 | $447,424 | |
| 6 | JNJ |
Johnson & Johnson
|
1,060 | $269,208 | |
| 7 | ABBV |
AbbVie Inc.
|
973 | $244,845 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,684,345 | 21,247 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,977,361 | 21,363 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,669,349 | 21,748 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,417,358 | 21,778 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,470,516 | 22,283 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,478,882 | 22,123 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,057,911 | 22,279 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,873,320 | 22,344 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,565,886 | 22,823 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,777,997 | 24,273 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,982,557 | 24,473 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,732,462 | 23,118 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,513,115 | 19,633 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,567,552 | 18,893 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,620,247 | 18,873 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $1,117,329 | 18,112 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,325,948 | 21,452 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,194,172 | 20,087 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,376,830 | 18,962 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,421,237 | 20,347 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,230,665 | 17,872 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,126,953 | 17,437 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,108,804 | 19,032 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,208,003 | 19,117 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,422,774 | 18,492 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,413,487 | 18,907 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||